Biofluids profile of α-Klotho in patients with Parkinson's disease

Parkinsonism Relat Disord. 2021 Sep:90:62-64. doi: 10.1016/j.parkreldis.2021.08.004. Epub 2021 Aug 10.

Abstract

We measured α-Klotho in CSF and serum of PD patients at early stage of the disease, finding two distinct pools, the first increased, the second reduced. CSF α-Klotho was inversely associated with CSF α-synuclein levels. Our preliminary results suggest α-Klotho as potential biomarker or therapeutic target in PD.

Keywords: Biomarkers; Blood; CSF; Parkinson's disease; α-Klotho.

Publication types

  • Letter

MeSH terms

  • Biomarkers / blood
  • Biomarkers / cerebrospinal fluid
  • Case-Control Studies
  • Female
  • Humans
  • Klotho Proteins / analysis*
  • Male
  • Middle Aged
  • Parkinson Disease / blood*
  • Parkinson Disease / cerebrospinal fluid*
  • alpha-Synuclein / cerebrospinal fluid

Substances

  • Biomarkers
  • alpha-Synuclein
  • Klotho Proteins